Toronto (Dec. 10, 2006) - Drs. Gordon Keller, Igor Jurisica, Thomas Kislinger, Shuzo Sugita and Elisabeth Tillier (pictured clockwise from top left) were awarded a total of $3.4M on December 7 from the Canada Research Chairs (CRC) program--a strategy initiated by the government of Canada to attract and retain the world's most accomplished and promising minds.
Embryonic stem cell biologist and new McEwen Centre Director Dr. Keller won a new Tier I CRC, which is awarded to outstanding researchers acknowledged by their peers as world leaders in their fields.
Drs. Jurisica, Kislinger and Tillier received new Tier II CRCs--given to exceptional emerging researchers, acknowledged by their peers as having the potential to lead in their field--and Dr. Sugita's existing Tier II CRC was successfully renewed. Their awards will support their programs in integrative computational biology (Dr. Jurisica), proteomics in cancer research (Dr. Kislinger), intercellular communication (Dr. Sugita) and analytical genomics (Dr. Tillier).
Drs. Jurisica, Keller and Kislinger were awarded a further $1M in infrastructure funding associated with their CRC awards from the Canada Foundation for Innovation, bringing the UHN awards announced this week to $4.4M total.
